| Primary |
| Asthma |
35.9% |
| Chronic Obstructive Pulmonary Disease |
24.8% |
| Hypertension |
8.4% |
| Bronchitis |
3.6% |
| Emphysema |
3.6% |
| Dyspnoea |
3.4% |
| Cardiac Failure |
2.2% |
| Hypothyroidism |
2.0% |
| Lung Disorder |
1.8% |
| Cardiac Disorder |
1.7% |
| Cough |
1.7% |
| Osteoporosis |
1.7% |
| Bronchospasm |
1.5% |
| Anxiety |
1.4% |
| Thyroid Disorder |
1.4% |
| Depression |
1.1% |
| Cardiac Failure Congestive |
1.0% |
| Pneumonia |
1.0% |
| Pulmonary Fibrosis |
1.0% |
| Blood Triglycerides |
0.8% |
|
| Death |
29.0% |
| Pneumonia |
10.2% |
| Tremor |
7.5% |
| Dyspnoea |
5.9% |
| Tachycardia |
5.5% |
| Wheezing |
4.7% |
| Asthma |
3.9% |
| Lung Neoplasm Malignant |
3.5% |
| Throat Irritation |
3.5% |
| Respiratory Failure |
3.1% |
| Surgery |
3.1% |
| Vomiting |
2.7% |
| Wrong Technique In Drug Usage Process |
2.7% |
| Myocardial Infarction |
2.4% |
| Pharmaceutical Product Complaint |
2.4% |
| Drug Ineffective |
2.0% |
| Incorrect Route Of Drug Administration |
2.0% |
| Medication Error |
2.0% |
| Positron Emission Tomogram Abnormal |
2.0% |
| Respiratory Arrest |
2.0% |
|
| Secondary |
| Asthma |
27.3% |
| Chronic Obstructive Pulmonary Disease |
20.0% |
| Hypertension |
8.8% |
| Drug Use For Unknown Indication |
8.2% |
| Product Used For Unknown Indication |
8.1% |
| Emphysema |
3.5% |
| Bronchitis |
3.0% |
| Depression |
2.5% |
| Cardiac Failure |
2.3% |
| Dyspnoea |
2.3% |
| Cardiac Disorder |
2.1% |
| Diabetes Mellitus |
1.8% |
| Osteoporosis |
1.7% |
| Prophylaxis |
1.4% |
| Sedation |
1.4% |
| Pain |
1.2% |
| Atrial Fibrillation |
1.1% |
| Hypersensitivity |
1.1% |
| Lung Disorder |
1.1% |
| Alcohol Withdrawal Syndrome |
1.0% |
|
| Dyspnoea |
9.6% |
| Asthma |
8.8% |
| Malaise |
6.1% |
| Throat Irritation |
6.1% |
| Toxic Epidermal Necrolysis |
6.1% |
| Tremor |
6.1% |
| Death |
5.3% |
| Drug Ineffective |
5.3% |
| Pneumonia |
5.3% |
| Wheezing |
5.3% |
| Fatigue |
4.4% |
| Treatment Noncompliance |
4.4% |
| Unresponsive To Stimuli |
4.4% |
| Bronchopulmonary Aspergillosis |
3.5% |
| Dyspnoea Exertional |
3.5% |
| Insomnia |
3.5% |
| Pulmonary Arterial Hypertension |
3.5% |
| Urticaria |
3.5% |
| General Physical Health Deterioration |
2.6% |
| Hypothyroidism |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
19.0% |
| Asthma |
18.6% |
| Chronic Obstructive Pulmonary Disease |
16.0% |
| Product Used For Unknown Indication |
14.9% |
| Hypertension |
5.7% |
| Emphysema |
3.7% |
| Pain |
2.2% |
| Dyspnoea |
2.2% |
| Osteoporosis |
2.0% |
| Hypersensitivity |
1.9% |
| Non-small Cell Lung Cancer |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Depression |
1.7% |
| Prophylaxis |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| Smoking Cessation Therapy |
1.3% |
| Blood Cholesterol Increased |
1.2% |
| Atrial Fibrillation |
1.2% |
| Diabetes Mellitus |
1.1% |
| Nausea |
1.0% |
|
| Dyspnoea |
11.5% |
| Drug Ineffective |
9.8% |
| Asthma |
6.9% |
| Weight Decreased |
6.7% |
| Vomiting |
6.3% |
| Death |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.8% |
| Wheezing |
4.6% |
| Nausea |
4.4% |
| Urticaria |
4.2% |
| Weight Increased |
4.2% |
| Pneumonia |
4.0% |
| Tremor |
4.0% |
| Sepsis |
3.8% |
| Rash |
3.4% |
| Respiratory Failure |
3.4% |
| Renal Failure Acute |
3.3% |
| Throat Tightness |
3.3% |
| Visual Impairment |
3.1% |
| Thrombocytopenia |
2.9% |
|
| Interacting |
| Asthma |
42.1% |
| Chronic Obstructive Pulmonary Disease |
21.1% |
| Atrial Fibrillation |
10.5% |
| Bipolar Disorder |
5.3% |
| Hiv Infection |
5.3% |
| Hypertension |
5.3% |
| Hypothyroidism |
5.3% |
| Smoking Cessation Therapy |
5.3% |
|
| Arthralgia |
14.3% |
| Dizziness |
14.3% |
| Hypocalcaemia |
14.3% |
| Obstructive Airways Disorder |
14.3% |
| Pneumonia |
14.3% |
| Tremor |
14.3% |
| Wheezing |
14.3% |
|
